Anzeige
Mehr »
Donnerstag, 10.07.2025 - Börsentäglich über 12.000 News
Schwergewicht aus London investiert Millionen in australisches Goldprojekt - was Anleger jetzt wissen müssen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
191 Leser
Artikel bewerten:
(1)

Catalyst Capital Markets LLC: Catalyst Capital Markets is a Proud Sponsor of the Advanced Wound Care Summit

BOSTON, MA / ACCESS Newswire / July 9, 2025 / Catalyst Capital Markets, LLC, a leading lower-middle market equity and debt capital markets advisory firm is a proud founding sponsor of the Investment Forum at the Advanced Wound Care Summit, taking place July 15-17 at the Courtyard Boston Downtown. The Investment Forum will take place on Tuesday, July 15th and will connect pioneering wound care companies with leading investors to fuel the next generation of breakthroughs.

Catalyst's Kris Tomasulo, a Managing Director with 25+ years of buy-and-sell side institutional healthcare experience, will be a featured panelist on the investment panel moderated by Ross Osborn, a publishing research analyst at Cantor Fitzgerald, along with key opinion leaders from the Wound Care space.

The Advanced Wound Care Summit, taking place July 15-17, will bring together global leaders in wound care innovation, clinical research, and advanced therapeutics to address unmet needs in chronic wound management. With a focus on accelerating product development and enhancing patient outcomes, the summit will feature keynote presentations, interactive panels, and strategic networking opportunities.

About Catalyst Capital Markets

Catalyst Capital Markets specializes in capital markets advisory and transaction management. Founded by a team of seasoned senior executives with more than 175 years of global, senior experience, we leverage our collective expertise into driving highly differentiated value and outcomes for our clients.

Collectively, our team has advised or executed on more than 1,000 debt and equity transactions totaling more than $500bn of proceeds over the past 40 years across every vertical.

About the Advanced Wound Care Summit

The event is organized by Kisaco Research, a global leader in industry-specific events that connect business leaders and innovators to accelerate progress and commercialization across healthcare, biotech, and life sciences.

Disclaimer

This material is intended for information purposes only and does not constitute investment advice, a recommendation or an offer or solicitation to purchase or sell any securities to any person in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. Unless otherwise stated, all views or opinions herein are solely those of the author(s), and thus any view, comments, or outlook expressed in this communication may differ substantially from any similar material issued by other persons or entities. The information contained in this communication is based on generally available information and although obtained from sources believed to be reliable, its accuracy and completeness cannot be assured and such information may be incomplete or condensed. The information in this communication does not constitute tax, financial, or legal advice. Securities are offered through Finalis Securities, LLC. Catalyst Capital Markets and Finalis Securities, LLC are separate unaffiliated entities.

To learn more about our team and platforms, please visit www.catalystcapmkts.com

Contact:

Brett Maas, Chief Executive Officer
Hayden IR, a Catalyst Strategic Holdings Partner
(646) 536-7331
info@catalystcapmkts.com

SOURCE: Catalyst Capital Markets LLC



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/banking-and-financial-services/catalyst-capital-markets-is-a-proud-sponsor-of-the-advanced-wound-ca-1047263

© 2025 ACCESS Newswire
Hensoldt, Renk & Rheinmetall teuer
Rheinmetall, Renk und Hensoldt haben den Rüstungsboom der letzten Jahre dominiert, doch inzwischen sind diese Titel fundamental heillos überbewertet. KGVs jenseits der 60, KUVs über 4, und das in einem politisch fragilen Umfeld mit wackelnder Haushaltsdisziplin. Für späteinsteigende Anleger kann das teuer werden.

Doch es gibt Alternativen, die bislang unter dem Radar fliegen; solide bewertet, operativ stark und mit Nachholpotenzial.

In unserem kostenlosen Report zeigen wir dir, welche 3 Rüstungsunternehmen noch Potenzial haben und wie du von der zweiten Welle der Zeitenwende profitieren kannst, ohne sich an überhitzten Highflyer zu verbrennen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders vom weltweiten Aufrüsten profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.